ArticleJournal of personalized medicine2021
Statistical Analysis of the Main Risk Factors of an Unfavorable Evolution in Gastroschisis.
Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 10 citations in OpenAlex.
- Mortality and Factors Associated with Death in Children with Congenital Gastrointestinal Malformations-A Five-Year Retrospective Study from Romania (2020-2024).Children (Basel, Switzerland) · 2026Article
- Congenital Gastrointestinal Malformations in a Romanian Tertiary Centre (2020-2024): A Retrospective Cohort Study of Diagnosis, Distribution, and Outcomes.Diagnostics (Basel, Switzerland) · 2026Article
- Association Between Congenital Gastrointestinal Malformation Outcome and Largely Asymptomatic SARS-CoV-2 Infection in Pediatric Patients-A Systematic Review.Journal of clinical medicine · 2025Review
- Prenatal Diagnosis of Reno-Urinary Malformations in a Tertiary Center of Republic of Moldavia.Diagnostics (Basel, Switzerland) · 2024Article
- Avoiding High Pressure Abdominal Closure of Congenital Abdominal Wall Defects-One Step Further to Improve Outcomes.Children (Basel, Switzerland) · 2023Article
- Omphalocele and Cardiac Abnormalities-The Importance of the Association.Diagnostics (Basel, Switzerland) · 2023Review
- Nosocomial Infections Affecting Newborns with Abdominal Wall Defects.Healthcare (Basel, Switzerland) · 2023Article
- Current Challenges in the Treatment of the Omphalocele-Experience of a Tertiary Center from Romania.Journal of clinical medicine · 2022Article
- Variations in Biochemical Values under Stress in Children with SARS-CoV-2 Infection.Diagnostics (Basel, Switzerland) · 2022Article
- The Impact of the Main Negative Socio-Economic Factors on Female Fertility.Healthcare (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastroschisis is a congenital abdominal wall defect that presents an increasing occurrence at great cost for the health system. The aim of the study is to detect the main factors of an unfavorable evolution in the case of gastroschisis and to find the best predictors of death.
methodswe conducted a retrospective cohort study of neonates with gastroschisis treated in a tertiary pediatric center during the last 30 years; 159 patients were eligible for the study. Logistic regression was used to determine the risk of death, estimated based on independent variables previously validated by the chi-square test.
resultsif the birth weight is below normal, then we find an increased risk (4.908 times) of evolution to death. Similarly, the risk of death is 7.782 times higher in the case of developing abdominal compartment syndrome, about 3 times in the case of sepsis and 7.883 times in the case of bronchopneumonia. All four independent variables contributed 47.6% to the risk of death.
conclusionalthough in the past 30 years in our country we have seen transformational improvements in outcome of gastroschisis, survival rates increasing from 26% to 52%, some factors may still be ameliorated for a better outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.